Mirna106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis:a cross sectional study

Emanuele D'Amico,Aurora Zanghi,Virginia Manuti,Gaetano Serviddio,Carlo Avolio

Frontiers in immunology（2023）

引用 0|浏览3

暂无评分

摘要

We described miRNA 106a-5p as a possible signature in the CSF of RRMS patients in early phases of the disease. Further studies are needed to characterize its role in early MS as a disease biomarker.

查看译文

关键词

multiple sclerosis,cerebrospinal fluid

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要